Early detection and treatment of heart failure
Part of Heart & circulation clinical trials.
This trial tests if a medication can prevent heart failure in older adults who are at risk. It is for people aged 65 or older who are having certain heart procedures or a major surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older.
- You are scheduled for a heart procedure (like a stent, pacemaker, or valve replacement), a major non-heart surgery, or you came to the emergency room with a fast heart rhythm.
- You do not have a history of heart failure.
- Your blood pressure is above 95 mmHg systolic.
- Your kidney function is above a certain level.
- You do not have dementia, advanced cancer, or severe valve disease.
- You can stay in the hospital overnight after the procedure.
- You are not allergic to the study medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether a medical patch called HEMOTAG can help doctors predict or track how patients do shortly after a hospital stay for worsening heart failure. It may help improve early monitoring and treatment decisions after discharge.
This trial tests a multidisciplinary care approach aimed at helping people with high risk for heart failure get diagnosed earlier. It may help you catch heart failure sooner if it starts, so treatment can begin earlier.
This trial tests a web-based prevention program for people recently hospitalized with heart failure (with low pumping ability). The goal is to help you stay healthier and avoid another hospital stay.
This trial tests if a personalized medication plan can improve health in women hospitalized with heart failure. It aims to find the best treatment combinations for better recovery.
This trial tests whether adding a heart failure medicine (SGLT-2 inhibitor) alongside probiotics helps older adults with a specific type of heart failure (HFpEF). It aims to improve symptoms and quality of life.
This study is looking for people who may have undiagnosed heart failure. It tests a self-screening method at home to find heart problems earlier.
Hear when a new Heart Failure (HF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.